AGEN Price / Book | AGENUS INC

AGENUS INC Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

AGENUS INC price/book ratio for the quarter ending 2026-06-30 was -0.65, a change of -0.27 year-over-year.
AGENUS INC price/book ratio for the quarter ending 2026-03-31 was -0.58, a change of -0.46 year-over-year.
AGENUS INC price/book ratio for the quarter ending 2025-12-31 was -0.41, a change of -0.21 year-over-year.
AGENUS INC price/book ratio for the quarter ending 2025-09-30 was -0.46, a change of -0.06 year-over-year.
AGENUS INC price/book ratio for fiscal 2026 was -0.65.
AGENUS INC price/book ratio for fiscal 2025 was -0.41, a change of -0.21 from fiscal 2024.
AGENUS INC price/book ratio for fiscal 2024 was -0.2, a change of 1.84 from fiscal 2023.
AGENUS INC price/book ratio for fiscal 2023 was -2.04, a change of 232.27 from fiscal 2022.

Available history: 2011-09-30 to 2026-06-30
Data captured: 2026-06-30

Historical Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	-0.65	$129.55M	-$199.08M
2026-03-31	-0.58	$128.28M	-$221.22M
2025-12-31	-0.41	$110.91M	-$271.11M
2025-09-30	-0.46	$126.99M	-$274.14M
2025-06-30	-0.38	$136.52M	-$354.6M
2025-03-31	-0.12	$40.11M	-$341.85M
2024-12-31	-0.2	$64.76M	-$326.38M
2024-09-30	-0.41	$118.83M	-$292.34M
2024-06-30	-1.47	$353.86M	-$241.31M
2024-03-31	-1.21	$243.53M	-$201.43M
2023-12-31	-2.04	$327.33M	-$160.33M
2023-09-30	-66.44	$8.58B	-$129.11M
2023-06-30	-119.79	$11.16B	-$93.2M
2023-03-31	-169.47	$9.92B	-$58.54M
2022-12-31	-234.31	$14.36B	-$61.28M
2022-09-30	-558.9	$11.39B	-$20.39M
2022-06-30	3,020.61	$10.32B	$3.42M
2022-03-31	789.93	$12.42B	$15.72M
2021-12-31	471.3	$16.23B	$34.44M
2021-09-30	573.92	$24.02B	$41.85M
2021-06-30	-96.99	$23.97B	-$247.12M
2021-03-31	-57.62	$10.93B	-$189.66M
2020-12-31	-58.27	$11.87B	-$203.67M
2020-09-30	-72.56	$14.4B	-$198.49M
2020-06-30	-59.9	$13.1B	-$218.62M
2020-03-31	-39.66	$7.77B	-$195.92M
2019-12-31	-48.69	$10.97B	-$225.36M
2019-09-30	-34.82	$6.95B	-$199.69M
2019-06-30	-50.28	$7.91B	-$157.23M
2019-03-31	-67.36	$7.82B	-$116.13M
2018-12-31	-32.5	$5.6B	-$172.47M
2018-09-30	-36.49	$4.76B	-$130.41M
2018-06-30	-41.11	$4.63B	-$112.71M
2018-03-31	-83.61	$9.48B	-$113.39M
2017-12-31	-84.55	$6.41B	-$75.82M
2017-09-30	-167.28	$8.63B	-$51.59M
2017-06-30	-435.14	$7.61B	-$17.48M
2017-03-31	817.06	$7.28B	$8.9M
2016-12-31	-180.07	$7.05B	-$39.13M
2016-09-30	-582.72	$12.26B	-$21.04M
2016-06-30	409.21	$6.91B	$16.88M
2016-03-31	158.91	$7.06B	$44.45M
2015-12-31	106.64	$7.54B	$70.73M
2015-09-30	98.88	$7.61B	$76.98M
2015-06-30	138.87	$12.11B	$87.19M
2015-03-31	154.01	$7.12B	$46.26M
2014-12-31	212.19	$4.88B	$23.02M
2014-09-30	78.29	$3.83B	$48.87M
2014-06-30	68.25	$3.93B	$57.63M
2014-03-31	61.12	$3.87B	$63.29M
2013-12-31	-410.21	$1.84B	-$4.48M
2013-09-30	-562.06	$1.62B	-$2.88M
2013-06-30	-121.97	$2.11B	-$17.26M
2013-03-31	-85.15	$1.93B	-$22.68M
2012-12-31	-112.45	$1.98B	-$17.6M
2012-09-30	-168.25	$2.21B	-$13.16M
2012-06-30	-206.29	$2.34B	-$11.36M
2012-03-31	-274.05	$2.91B	-$10.63M
2011-12-31	-40.43	$842.21M	-$20.83M
2011-09-30	-393.31	$6.32B	-$16.07M

Annual Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	-0.65	$129.55M	-$199.08M
2025-12-31	-0.41	$110.91M	-$271.11M
2024-12-31	-0.2	$64.76M	-$326.38M
2023-12-31	-2.04	$327.33M	-$160.33M
2022-12-31	-234.31	$14.36B	-$61.28M
2021-12-31	471.3	$16.23B	$34.44M
2020-12-31	-58.27	$11.87B	-$203.67M
2019-12-31	-48.69	$10.97B	-$225.36M
2018-12-31	-32.5	$5.6B	-$172.47M
2017-12-31	-84.55	$6.41B	-$75.82M
2016-12-31	-180.07	$7.05B	-$39.13M
2015-12-31	106.64	$7.54B	$70.73M
2014-12-31	212.19	$4.88B	$23.02M
2013-12-31	-410.21	$1.84B	-$4.48M
2012-12-31	-112.45	$1.98B	-$17.6M
2011-12-31	-40.43	$842.21M	-$20.83M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
C4 Therapeutics, Inc. (CCCC)	United States	$0.373B	-5.65
FENNEC PHARMACEUTICALS INC. (FENC)	United States	$0.371B	-115.85
Surrozen, Inc./DE (SRZN)	United States	$0.395B
Zura Bio Ltd (ZURA)		$0.398B	-6.56
Artiva Biotherapeutics, Inc. (ARTV)	United States	$0.367B
Cabaletta Bio, Inc. (CABA)	United States	$0.365B	-2.81
Scribe Therapeutics, Inc. (SCTX)	United States	$0.410B
Ocugen, Inc. (OCGN)	United States	$0.343B	-6.34
Editas Medicine, Inc. (EDIT)	United States	$0.424B	-4.29
Kyverna Therapeutics, Inc. (KYTX)	United States	$0.434B	-3.60